09.10.2018 • NewsAkzoNobelElaine BurridgeNouryon

AkzoNobel Specialty Chemicals Relaunched as Nouryon

AkzoNobel Specialty Chemicals has been relaunched as Nouryon
AkzoNobel Specialty Chemicals has been relaunched as Nouryon

AkzoNobel's former Specialty Chemicals business has been relaunched as Nouryon. The move follows its acquisition by Carlyle and GIC, which closed on Oct. 1.

“We are starting from a great position,” said Nouryon CEO Charles Shaver. “We have a great set of businesses, leadership positions across our portfolio, long-term customer partnerships, and a dedication to continuous improvement and innovation we can leverage for further success. As an independent company we can accelerate our progress on all fronts and take our rightful place alongside other industry leaders.”

The company said the Nouryon name and brand identity reflects a history that stretches back nearly 400 years. “When we started developing our new name and brand we asked our employees what mattered most to them,” explained Vivi Hollertt, Chief Communications Officer at Nouryon. “Our employees are especially proud of our heritage, as well our track record of growing through partnerships, innovation, sustainability, and contributing to society. We combined all of this to create a brand identity for Nouryon which is true to who we are and helps us stand out from our competitors.”

Nouryon said it will be working closely with customers and other partners to innovate, make strategic investments and develop essential, sustainable solutions that meet customer needs and fuel shared growth.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.